Oncotelic Therapeutics (OTLC) Receivables (2019 - 2026)
Oncotelic Therapeutics (OTLC) posted Receivables of $2,058 for Q2 2026, down 89.2% from $18,976 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics' Receivables came in at $51,324, up 170.5% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of -10.6% (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Receivables was $18,976 in FY2024 (unchanged), $18,976 in FY2023 (-3.9%), $19,748 in FY2022 (unchanged) and $19,748 in FY2021 (-78.0%).
- The Q2 2026 figure stands as the lowest quarterly Receivables in data going back to Q4 2019.
- On a year-over-year basis, Receivables increased in 1 of the last seven quarters, with growth averaging 0.3%.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2025, with growth of 170.5%; the weakest was Q2 2026, with a decline of 89.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | 2,058.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,058.00 |
| Dec 31, 2025 | 51,324.00 |
| Sep 30, 2025 | 3,976.00 |
| Jun 30, 2025 | 18,976.00 |
| Mar 31, 2025 | 18,976.00 |
| Dec 31, 2024 | 18,976.00 |
| Sep 30, 2024 | 18,976.00 |
| Jun 30, 2024 | 18,976.00 |
| Mar 31, 2024 | 18,976.00 |
| Dec 31, 2023 | 18,976.00 |
| Sep 30, 2023 | 18,976.00 |
| Jun 30, 2023 | 18,976.00 |
| Mar 31, 2023 | 19,748.00 |
| Dec 31, 2022 | 19,748.00 |
| Sep 30, 2022 | 19,748.00 |
| Jun 30, 2022 | 19,748.00 |
| Mar 31, 2022 | 19,748.00 |
| Dec 31, 2021 | 19,748.00 |
| Sep 30, 2021 | 69,806.00 |
| Jun 30, 2021 | 156,270.00 |
API Access
Oncotelic Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();